02/01/12 - Sophia-Antipolis, France

MEDIAN signe un contrat majeur avec Sanofi

MEDIAN Technologies signe un contrat majeur avec le laboratoire SANOFI pour l’interprétation et la gestion des images dans une nouvelle étude de phase II sur le cancer du poumon à petites cellules.

 

02/01/12 - Sophia-Antipolis, France

MEDIAN has signed a landmark contract with Sanofi

MEDIAN Technologies has signed a landmark contract with the top pharmaceutical company SANOFI for medical image interpretation and management in a new phase II study on small cells lung cancer.

 
 

Products

MEDIAN LMS – Lesion Management Solutions – is a comprehensive portfolio of clinical applications for the management of cancerous or suspicious lesions diagnosed in CT scans.

These applications provide:

  • Quantitative management of response to therapy in oncology patients including patients enrolled in clinical trials
  • Computer aided detection and follow-up of indeterminate lung nodules


All LMS applications are designed to be fully integrated in clinical routine, and so are available on various enterprise-wide environments including PACS or RIS workstations in single or multi-site environments.

Today, the LMS line includes the following products:

  • LMS-Lung: clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest
  • LMS-Lung/Track: clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest
  • LMS-Liver: Clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver